Valentina Lukashevich

Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy

Scott D. Solomon, Evan Appelbaum, Warren J. Manning et al. · Circulation · 2009 · 307 citations · Full text

Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure

John J.V. McMurray, Piotr Ponikowski, Geremia B. Bolli et al. · JACC Heart Failure · 2017 · 160 citations · Full text

Metabolic Syndrome, Heart Failure, Cardiovascular Disease +9

Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24‐week randomized placebo‐controlled trial

Valentina Lukashevich, Anja Schweizer, Q. Shao et al. · Diabetes Obesity and Metabolism · 2011 · 146 citations

Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study

W. David Strain, Valentina Lukashevich, Wolfgang Kothny et al. · The Lancet · 2013 · 138 citations

Non-pharmacological Intervention, Diabetes Management, Elderly Patients +9

One‐year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment

Wolfgang Kothny, Q. Shao, Per‐Henrik Groop et al. · Diabetes Obesity and Metabolism · 2012 · 103 citations